Dr. Aly-Khan Lalani, MD
Claim this profileJuravinski Cancer Centre
Studies Renal Cell Carcinoma
Studies Kidney Tumors
2 reported clinical trials
4 drugs studied
More about Aly-Khan Lalani, MD
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Aly-Khan Lalani, MD has experience with
- Ipilimumab/Nivolumab
- SBRT
- Durvalumab
- Immune Modulating Radiation
Breakdown of trials Aly-Khan Lalani, MD has run
Renal Cell Carcinoma
Kidney Tumors
Kidney Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aly-Khan Lalani, MD specialize in?
Aly-Khan Lalani, MD focuses on Renal Cell Carcinoma and Kidney Tumors. In particular, much of their work with Renal Cell Carcinoma has involved Stage IV patients, or patients who are undergoing treatment.
Is Aly-Khan Lalani, MD currently recruiting for clinical trials?
No, Aly-Khan Lalani, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Aly-Khan Lalani, MD has studied deeply?
Yes, Aly-Khan Lalani, MD has studied treatments such as Ipilimumab/Nivolumab, SBRT, Durvalumab.
What is the best way to schedule an appointment with Aly-Khan Lalani, MD?
Apply for one of the trials that Aly-Khan Lalani, MD is conducting.
What is the office address of Aly-Khan Lalani, MD?
The office of Aly-Khan Lalani, MD is located at: Juravinski Cancer Centre, Hamilton, Ontario Canada. This is the address for their practice at the Juravinski Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.